I5250
myo-Inositol 2-monophosphate bis(cyclohexylammonium) salt
~95%, powder
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C6H13O9P · 2C6H13N
化学文摘社编号:
分子量:
458.48
PubChem Substance ID:
UNSPSC Code:
12352201
Beilstein/REAXYS Number:
3923086
MDL number:
SMILES string
NC1CCCCC1.NC2CCCCC2.O[C@@H]3[C@@H](O)[C@H](O)[C@H](OP(O)(O)=O)[C@H](O)[C@H]3O
InChI
1S/2C6H13N.C6H13O9P/c2*7-6-4-2-1-3-5-6;7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h2*6H,1-5,7H2;1-11H,(H2,12,13,14)/t;;1-,2-,3+,4+,5-,6+
InChI key
IMIHZMWNWGIJKQ-YAUWMCRJSA-N
assay
~95%
form
powder
color
white
正在寻找类似产品? 访问 产品对比指南
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
新产品
此项目有
Sophie J Bradley et al.
Nature chemical biology, 16(3), 240-249 (2020-02-23)
Cholinesterase inhibitors, the current frontline symptomatic treatment for Alzheimer's disease (AD), are associated with low efficacy and adverse effects. M1 muscarinic acetylcholine receptors (M1 mAChRs) represent a potential alternate therapeutic target; however, drug discovery programs focused on this G protein-coupled
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持